Thor Medical ASA Logo

Thor Medical ASA

Producer and supplier of alpha-particle emitters for cancer therapy.

NANOV | OL

Overview

Corporate Details

ISIN(s):
NO0010597883 (+1 more)
LEI:
5967007LIEEXZXG6DK30
Country:
Norway
Address:
Drammensveien 167, 0277 Oslo

Description

Thor Medical ASA is a producer and supplier of alpha-particle emitters for cancer therapy. The company specializes in manufacturing isotopes, such as Thorium-228, by separating decay products from naturally occurring Thorium-232. This is achieved through a proprietary production technology that offers high efficiency, cost-competitiveness, and superior environmental friendliness. The company provides these critical alpha-emitters to partners developing next-generation targeted alpha therapies for precision oncology.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-23 08:00
Thor Medical reaches key construction milestones at AlphaOne plant - Attachment…
English 48.7 KB
2025-12-23 08:00
Thor Medical reaches key construction milestones at AlphaOne plant
English 3.2 KB
2025-12-04 08:00
RadioMedix and Thor Medical enter supply agreement for thorium-228 - Attachment…
English 53.4 KB
2025-12-04 08:00
RadioMedix and Thor Medical enter supply agreement for thorium-228
English 4.2 KB
2025-11-20 13:27
Thor Medical ASA - New share capital registered - Attachment: Download announce…
Norwegian 45.8 KB
2025-11-20 13:27
Thor Medical ASA - New share capital registered
English 1.9 KB
2025-11-20 07:30
Thor Medical enters supply agreement with NucliThera for thorium-228 - Attachme…
Norwegian 54.8 KB
2025-11-20 07:30
Thor Medical enters supply agreement with NucliThera for thorium-228
English 4.2 KB
2025-11-11 23:15
Thor Medical - Issuance of RSU shares to members of the board - Attachment: 202…
Norwegian 93.5 KB
2025-11-11 23:15
Thor Medical - Issuance of RSU shares to members of the board - Attachment: 202…
Norwegian 93.0 KB
2025-11-11 23:15
Thor Medical - Issuance of RSU shares to members of the board - Attachment: Dow…
Norwegian 50.5 KB
2025-11-11 23:15
Thor Medical - Issuance of RSU shares to members of the board
English 2.5 KB
2025-11-06 07:30
Thor Medical and Telix Pharmaceuticals sign strategic supply agreement for thor…
English 56.4 KB
2025-11-06 07:30
Thor Medical and Telix Pharmaceuticals sign strategic supply agreement for thor…
English 6.2 KB
2025-08-22 08:00
Invitation to presentation of Thor Medical ASA's 1H 2025 on Friday 29 August at…
English 50.3 KB

Automate Your Workflow. Get a real-time feed of all Thor Medical ASA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Thor Medical ASA

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Thor Medical ASA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.